The online interaction and matchmaking systems of euroPLX Conferences provide 25 to 30 pre-arranged business meetings per attending company. It is the preferred partnering platform for new business opportunities since almost 24 years. Information exchange and interaction between confirmed registrants starts right after registration, intensifying during the month before the conference with two days of targeted, pre-scheduled one-on-one meetings of top executives of drug developing, producing or marketing companies from all over the world.

The partnering scope ranges from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices: development, licensing, marketing, promotion, and distribution. The „Dynamic Partnering Focus“ of this conference shows up on this page as soon as a sufficient number of collaboration interests are submitted. In addition, attending companies may offer or look for R&D services, supporting technologies (e.g. new drug delivery), contract manufacture, and the supply of APIs and intermediates.

We’re looking forward to attending this event and hope to see you there!

Additional News

  • 22 června 2023

    Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

    EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency

  • 15 června 2023

    Novavax & Conscio: Behind the Scenes of Vaccine Development

    Discover how the Conscio Group and renowned vaccine manufacturer Novavax collaborate behind the scenes to ensure quality and efficiency in vaccine production.

  • 8 června 2023

    Clinical Tips – Drug Interactions in Advanced Clinical Trial Design

    Drug interactions play a key role in the design of clinical trials. Learn how we investigate such interactions when conducting pharmacokinetic/bioequivalence studies and while offering end-to-end support throughout the process.